Tigo, Merasol .
HRN: 13-38-73 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2024
CEFTRIAXONE 1G (VIAL)
02/05/2024
02/11/2024
IV
2g
OD
UTI
Waiting Final Action